Description
1. An overview of veterinary viral diseases and vaccine technologies Alejandro Brun 2 .Production and purification of candidate subunit vaccines by IC-tagging protein encapsulation Natalia Barreiro-Pieiro; Toms Pose Boirazian; Rebeca Menaya-Varga, and Jos M. Martnez-Costas. 3. Elastin-like polymers as nanovaccines: protein engineering of self-assembled, epitope-exposing nanoparticles Alessandra Girotti, Juan Gonzlez-Valdivieso, Irene Alonso-Sampedro, Sara Escalera-Anzola, Sandra Ramos-Dez, and F. Javier Arias 4. Display of heterologous proteins in Bacillus subtilis biofilms for enteric immunization Ramona Wissmann, Cornel Fraefel, Claudio Aguilar, and Catherine Eichwald 5. Production of influenza H5 vaccine oligomers in plants Hoang Trong Phan and Udo Conrad Chapter 6 DNA vaccines in pigs: from immunization to antigen identification. Francesc Accensi, Laia Bosch-Cams, Paula L. Monteagudo and Fernando Rodrguez 7. Use of foot-and-mouth disease virus non-coding synthetic RNAs as vaccine adjuvants Miguel Rodrguez-Pulido, Miryam Polo, Beln Borrego, and Margarita Siz 8. Evaluation of innate lymphoid cells and dendritic cells following viral vector vaccination. Zheyi Li, Sreeja Roy, and Charani Ranasinghe 9. Generation of replication deficient human adenovirus 5 (Ad5) vectored FMD vaccines. Gisselle N. Medina, Teresa de los Santos, and Fayna Diaz-San Segundo 10. Recombinant modified vaccinia virus Ankara development to express VP2, NS1, and VP7 proteins of Bluetongue virus Alejandro Marn-Lpez, Sergio Utrilla-Trigo, Luis Jimnez-Cabello, and Javier Ortego. 11. Cloning strategies for the generation of recombinant capripoxvirus through the use of screening and selection markers Hani Boshra, Mahder Teffera, Jinxing Cao, and Shawn Babiuk 12. Using Rift Valley fever virus as a vector platform for the expression of ruminant disease antigens Sandra Moreno Beln Borrego and Alejandro Brun 13. Generation and characterization of single-cycle infectious canine Influenza A Virus (sciCIV) and its use as vaccine platform Aitor Nogales, Kevin Chiem, Michael Breen, Marta L DeDiego, Colin R Parrish, and Luis Martnez-Sobrido 14. Reverse genetics for influenza A and B viruses driven by swine polymerase I promoter. Brittany Seibert, Stivalis Cardenas-Garcia, Daniela Rajao, and Daniel R. Perez 15. Analysis of the cellular immune responses to vaccines Nicholas Svitek, Evans L. N. Taracha, Rosemary Saya, Elias Awino, Vish Nene, and Lucilla Steinaa
